高血压和心力衰竭:从病理生理学到治疗
Giovanna Gallo1, Carmine Savoia1
1Clinical and Molecular Medicine Department, Faculty of Medicine and Psychology, Sant'Andrea Hospital, Sapienza University of Rome, 00189 Rome, Italy.
International journal of molecular sciences
|June 27, 2024
概括
高血压是心力衰竭的主要风险因素. 控制血压 (BP) 减少事件,但需要澄清心力衰竭 (HF) 患者的BP目标,特别是在保留喷射分数 (HFpEF) 的HF.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 内分泌学 在内分泌学.
背景情况:
- 高血压是所有射出分数范围内的心力衰竭 (HF) 的主要危险因素.
- 充分控制血压 (BP) 已被证明可以减少心血管事件,包括HF的发展.
- 当前高血压管理在高血压往往从一般高血压人口的数据,而不是高血压特定的研究外推.
研究的目的:
- 澄清心力衰竭 (HF) 患者高血压管理中的关键问题,特别是关于血压 (BP) 目标.
- 审查各种抗高血压药物和新药在高血压患者高血压管理中的作用.
- 探索高血压指示药物的血压降低作用,如SGLT2抑制剂和finerenone.
主要方法:
- 对高血压和高血压管理现有证据的审查.
- 药物类别的分析,记录了结果的好处和降血压效应.
- 检查新兴疗法,包括SGLT2抑制剂,芬和小干扰RNA.
主要成果:
- 建议在降低射出分数 (HFrEF) 的高血压中进行组合治疗.
- 主要的抗高血压药物类别被推用于保持喷射分数 (HFpEF) 的高血压.
- 在高压环境中,SGLT2 抑制剂和芬瑞龙表现出有益的血压降低作用和心血管结果.
结论:
- 在高血压患者中优化血压目标需要进一步的研究,而不仅仅是一般人群数据.
- 新型药物,如SGLT2抑制剂和finerenone在治疗高血压和改善高血压患者的结果方面表现有前途.
- 像小干扰RNA这样的新兴策略需要对未来的高血压和高血压管理进行调查.
相关概念视频
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
419
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
419
Heart Failure Drugs: Diuretics
362
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
362
Hypertension and Regulation of Blood Pressure
2.0K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.0K
Heart Failure Drugs: β-Blockers
336
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
336
Pulmonary Hypertension: Classification and Pathogenesis
168
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
168


